<title>2142</title>
<html><head><!-- This document was created from RTF source by rtftohtml version
2.6 -->2.0  STUDY OBJECTIVES<p>
<p>
2.1  Primary<p>
<p>
To compare the immunogenicity and safety of several HIV-1 derived immunogens in
HIV-infected individuals with CD4 counts &gt;= 500/mm^3.<p>
<p>
2.2  Secondary<p>
<p>
To determine whether there are significant advantages to any one of these
vaccines.
</body></html>